Stock-Based Compensation Expense (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of stock options vested and exercisable

	Shares			Weighted-average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Outstanding as of December 31, 2021		8,769,694		$	1.20		7.15	$	15,746,916
Granted		6,842,500			1.20
Exercised		(717,041	)		0.16				1,012,175
Cancelled/forfeited		(180,043	)	$	2.77
Outstanding as of December 31, 2022		14,715,110		$	1.23		7.84	$	2,571,013
Vested and expected to vest at December 31, 2022		14,715,110		$	1.23		7.84	$	2,571,013
Vested and exercisable at December 31, 2022		6,266,135		$	0.73		5.65	$	2,555,579

Schedule of restricted stock units and activity

	Shares			Weighted- average grant date fair value
Unvested shares at December 31, 2021		-		$	-
RSUs granted		244,566			5.52
RSUs vested		(28,530	)		5.52
RSUs forfeited		-			-
Unvested Shares at December 31, 2022		216,036		$	5.52

Schedule of weighted average fair value of each grant estimated on grant date

	December 31,
	2022			2021
Fair value of common stock	$	1.20		$	2.78
Expected term (in years)		6.03			6.15
Risk-free rate		3.77	%		0.95	%
Expected volatility		48.72	%		51.0	%
Dividend yield		0	%		0	%